K. Olek

2.9k total citations
103 papers, 2.2k citations indexed

About

K. Olek is a scholar working on Molecular Biology, Hematology and Clinical Biochemistry. According to data from OpenAlex, K. Olek has authored 103 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Molecular Biology, 31 papers in Hematology and 18 papers in Clinical Biochemistry. Recurrent topics in K. Olek's work include Hemophilia Treatment and Research (26 papers), Metabolism and Genetic Disorders (18 papers) and Cancer-related gene regulation (18 papers). K. Olek is often cited by papers focused on Hemophilia Treatment and Research (26 papers), Metabolism and Genetic Disorders (18 papers) and Cancer-related gene regulation (18 papers). K. Olek collaborates with scholars based in Germany, United Kingdom and United States. K. Olek's co-authors include R. Schwaab, Johannes Oldenburg, Edward G. D. Tuddenham, Michael Kirchgesser, Miyoko Higuchi, Michael Ludwig, J.-P. Faber, Wolfgang Poller, H.H. Brackmann and Hans‐Hermann Brackmann and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Nucleic Acids Research.

In The Last Decade

K. Olek

99 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K. Olek Germany 25 1.1k 963 282 215 192 103 2.2k
Chiara Romano Italy 23 562 0.5× 233 0.2× 101 0.4× 232 1.1× 97 0.5× 67 1.4k
Ernst W. Müllner Austria 24 1.8k 1.6× 721 0.7× 142 0.5× 522 2.4× 95 0.5× 53 3.0k
Francisco J. Iborra United Kingdom 32 3.4k 3.0× 218 0.2× 357 1.3× 137 0.6× 60 0.3× 62 4.1k
M J A Tanner United Kingdom 29 1.3k 1.1× 840 0.9× 246 0.9× 173 0.8× 237 1.2× 47 2.6k
Christopher L. Reading United States 19 731 0.6× 448 0.5× 190 0.7× 218 1.0× 81 0.4× 74 1.8k
Venkatesha Basrur United States 30 2.5k 2.2× 334 0.3× 366 1.3× 116 0.5× 138 0.7× 86 3.2k
Jean‐Pierre Kerckaert France 26 1.3k 1.2× 241 0.3× 259 0.9× 387 1.8× 63 0.3× 61 2.4k
Rainer Prohaska Austria 30 1.7k 1.5× 205 0.2× 125 0.4× 131 0.6× 252 1.3× 54 2.8k
Gaëtan Chicanne France 28 1.4k 1.2× 546 0.6× 119 0.4× 212 1.0× 78 0.4× 57 2.4k
Kathryn M. John United States 18 1.2k 1.0× 121 0.1× 137 0.5× 179 0.8× 321 1.7× 22 2.2k

Countries citing papers authored by K. Olek

Since Specialization
Citations

This map shows the geographic impact of K. Olek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Olek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Olek more than expected).

Fields of papers citing papers by K. Olek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Olek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Olek. The network helps show where K. Olek may publish in the future.

Co-authorship network of co-authors of K. Olek

This figure shows the co-authorship network connecting the top 25 collaborators of K. Olek. A scholar is included among the top collaborators of K. Olek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Olek. K. Olek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Olek, K., Wyatt W. Yue, G.A. Bezerra, & Tim Skern. (2021). Defining substrate selection by rhinoviral 2A proteinase through its crystal structure with the inhibitor zVAM.fmk. Virology. 562. 128–141. 2 indexed citations
2.
Visser, Linda J., Kirby N. Swatek, Gisselle N. Medina, et al.. (2020). Dissecting distinct proteolytic activities of FMDV Lpro implicates cleavage and degradation of RLR signaling proteins, not its deISGylase/DUB activity, in type I interferon suppression. PLoS Pathogens. 16(7). e1008702–e1008702. 30 indexed citations
3.
Kaufmann, Tanja, Irina Grishkovskaya, Anton A. Polyansky, et al.. (2017). A novel non-canonical PIP-box mediates PARG interaction with PCNA. Nucleic Acids Research. 45(16). 9741–9759. 35 indexed citations
4.
Huber, K., K. Olek, André C. Müller, et al.. (2015). Proteome-wide drug and metabolite interaction mapping by thermal-stability profiling. Nature Methods. 12(11). 1055–1057. 162 indexed citations
5.
Griesenbach, Uta, Arcadio Chonn, Vicky Hannam, et al.. (1998). Comparison between intratracheal and intravenous administration of liposome–DNA complexes for cystic fibrosis lung gene therapy. Gene Therapy. 5(2). 181–188. 63 indexed citations
6.
Olek, K., et al.. (1997). [Maternal transmission or bovine spongiform encephalopathy in the case of "Cindy" disproved].. PubMed. 110(9). 305–10. 1 indexed citations
7.
Schwaab, R., et al.. (1995). Characterization of mutations within the factor VIII gene of 73 unrelated mild and moderate haemophiliacs. British Journal of Haematology. 91(2). 458–464. 52 indexed citations
8.
Oldenburg, Johannes, R. Schwaab, T. Grimm, et al.. (1993). Direct and indirect estimation of the sex ratio of mutation frequencies in hemophilia A.. PubMed. 53(6). 1229–38. 19 indexed citations
9.
Ludwig, Michael, Hans‐Hermann Brackmann, & K. Olek. (1991). Prenatal diagnosis of haemophilia B by the use of polymerase chain reaction and direct sequencing. Journal of Molecular Medicine. 69(5). 196–200. 7 indexed citations
10.
Giannelli, F., KA High, David Lillicrap, et al.. (1990). Haemophilia B: database of point mutations and short additions and deletions. Nucleic Acids Research. 18(14). 4053–4059. 59 indexed citations
11.
Weber, John, Andreas Weith, R. Kaiser, Karl‐Heinz Grzeschik, & K. Olek. (1990). Microdissection and microcloning of human chromosome 7q22-32 region. Somatic Cell and Molecular Genetics. 16(2). 123–128. 8 indexed citations
12.
Faber, J.-P., Stephan Weidinger, & K. Olek. (1990). Sequence data of the rare deficient alpha 1-antitrypsin variant PI Zaugsburg.. PubMed. 46(6). 1158–62. 12 indexed citations
13.
Knorr, Dietrich, et al.. (1990). HLA Class I-, Complement C4- and 21-Hydroxylase Probes in the Genetic Analysis of 21-Hydroxylase Deficiency. Clinical Chemistry and Laboratory Medicine (CCLM). 28(6). 413–7. 2 indexed citations
14.
Aulehla‐Scholz, C., Matthias Vorgerd, D. Leupold, et al.. (1988). Phenylketonuria: distribution of DNA diagnostic patterns in German families. Human Genetics. 78(4). 353–355. 40 indexed citations
15.
Weber, John, C. Aulehla‐Scholz, R. Kaiser, et al.. (1988). Cystic fibrosis: typing 89 German families with linked DNA probes. Human Genetics. 81(1). 54–56. 11 indexed citations
16.
Tesch, Hans, et al.. (1988). RFLP of the human c-fes proto-oncogene. Nucleic Acids Research. 16(9). 4193–4193. 2 indexed citations
17.
Higuchi, Miyoko, et al.. (1987). Human cDNA probe (OL167, D21S109) detects RFLP on chromosome 21. Nucleic Acids Research. 15(18). 7658–7658. 1 indexed citations
18.
Wille, Wolfgang, et al.. (1984). Construction and characterization of 3 age specific and region specific complementary dna expression libraries of the mouse brain. The Society for Neuroscience Abstracts. 10(1). 374. 1 indexed citations
19.
Olek, K.. (1978). [Gas chromatographic estimation of acidic urinary metabolites after separation on prepacked silica gel columns (author's transl)].. PubMed. 145(3). 341–50. 4 indexed citations
20.
Olek, K., et al.. (1977). [Quantitative determination of aromatic carboxylic acids with glass-capillary-columns (author's transl)].. PubMed. 15(12). 657–62. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chiara Romano Breakdown of academic impact, for papers by Ernst W. Müllner Breakdown of academic impact, for papers by Francisco J. Iborra Breakdown of academic impact, for papers by M J A Tanner Breakdown of academic impact, for papers by Christopher L. Reading Breakdown of academic impact, for papers by Venkatesha Basrur Breakdown of academic impact, for papers by Jean‐Pierre Kerckaert Breakdown of academic impact, for papers by Rainer Prohaska Breakdown of academic impact, for papers by Gaëtan Chicanne Breakdown of academic impact, for papers by Kathryn M. John
Rankless by CCL
2026